Customer Identity and Access Management Market to Reach $12.5 Billion by 2030, Growing at 9.53% CAGR, Reveals QKS Group Customer Identity and Access Management (CIAM) market is experiencing significant acceleration, with QKS Group revealing that the market is projected to reach a valuation of $12.5 billion by 2030, growing at a robust CAGR of 9.53% from 2025 to 2030. This growth reflects the critical role CIAM solutions now play in a digitally driven world where secure customer access, privacy protection, and seamless digital experiences are essential for business success. Click Here For More: https://qksgroup.com/market-research/market-forecast-customer-identity-and-access-management-2025-2030-worldwide-2286 A New Era of Customer Identity Security Modern businesses operate in an increasingly complex environment where customer interactions are digital-first, and online transactions are the norm. As users engage across multiple platforms-mobile apps, web portals, cloud services-organizations must ensure that identity management is secure, scalable, and user-friendly. Traditional authentication approaches are no longer sufficient to combat sophisticated cyber threats and evolving privacy expectations. CIAM solutions provide advanced capabilities such as multi-factor authentication (MFA), single sign-on (SSO), biometric authentication, consent management, and real-time fraud prevention. These capabilities ensure that businesses can validate customer identities without creating friction in user experience-an important factor as consumers demand both security and convenience. Regulatory Pressure and Data Privacy Compliance Global data protection regulations, including the General Data Protection Regulation (GDPR) in Europe and the California Consumer Privacy Act (CCPA) in the United States, have fundamentally changed how organizations collect, process, and store customer information. Non-compliance can result in heavy penalties, revenue losses, and damage to brand trust. CIAM solutions offer capabilities such as customer consent tracking, privacy preference management, and secure storage of personally identifiable information (PII). These solutions give organizations visibility and control over identity-related data to ensure that privacy requirements are consistently met across applications and regions. As new privacy laws emerge across Asia-Pacific, Middle East, and Latin America, compliance-driven adoption of CIAM technology is expected to increase, further fueling market growth. Customer Identity and Access Management: https://qksgroup.com/market-research/market-share-customer-identity-and-access-management-2024-worldwide-2482 Digital Transformation and Customer Experience Are Key Growth Drivers Businesses are prioritizing digital transformation to stay competitive, creating demand for secure and frictionless digital access. CIAM platforms enable streamlined customer onboarding, passwordless access, and omnichannel identity experiences-capabilities that directly enhance customer satisfaction and loyalty. Industries driving CIAM adoption include: Banking and Financial Services (BFSI) - Secure digital onboarding and fraud prevention Retail and E-commerce - Personalized experiences and secure checkout Healthcare - Protected access to sensitive patient information Telecom and Media - Unified digital identity and subscriber management Government and Public Services - Verified citizen identity and secure service delivery Why Investing in CIAM Is Critical for the Future As cyber threats evolve and customer expectations increase, organizations cannot afford to rely on outdated identity tools. Investing in advanced CIAM solutions enables enterprises to: • Protect sensitive customer data and reduce identity fraud • Ensure compliance with global privacy regulations • Deliver seamless and secure customer experiences • Scale securely across digital platforms and channels • Support long-term digital transformation strategies Download Free Sample Report Here: https://qksgroup.com/download-sample-form/market-forecast-customer-identity-and-access-management-2025-2030-worldwide-2286 Conclusion With a projected market value of $12.5 billion by 2030, CIAM is becoming a foundational technology for enterprises worldwide. Organizations that invest in modern CIAM solutions will not only strengthen data security and regulatory compliance but also enhance customer trust-an invaluable competitive advantage in the digital economy. The future of customer identity is secure, intelligent, and experience-driven-and CIAM will be at the core of this transformation. Key questions this study will answer: At what pace is the “Customer Identity and Access Management (CIAM)” market growing? What are the key market accelerators and market restraints impacting the global “Customer Identity and Access Management (CIAM)” market? Which industries offer maximum growth opportunities during the forecast period? Which global region expects maximum growth opportunities in the “Customer Identity and Access Management (CIAM)” market? Which customer segments have the maximum growth potential for the “Customer Identity and Access Management (CIAM)” solution? Which deployment options of “Customer Identity and Access Management (CIAM)” solutions are expected to grow faster in the next 5 years?

Global Grain Dryer Market to Grow at 7.8% CAGR Through 2031 Driven by Rising Need for Preserved Grains The latest market study, Global Grain Dryer Market Size, Share and Trends Analysis Report 2023-2031, highlights significant expansion ahead for the industry. The global grain dryer market is projected to expand at a robust 7.8% CAGR over the forecast period 2023-2031, driven by increasing adoption of advanced drying technologies and strong demand for preserved grain storage solutions. Market Size (Base Year and Forecast Year) Base Year: 2023 Forecast Year: 2031 CAGR: 7.8% expected during 2023-2031 To more info- https://reedintelligence.com/market-analysis/global-grain-dryer-market Key Highlights Largest Region: North America maintains a strong market position supported by advanced technologies and demand dynamics. Fastest-Growing Region: Asia-Pacific is experiencing remarkable growth driven by emerging economies and expanding agricultural sectors. Largest Segment: Stationary and mobile dryers dominate overall market share when analyzed by type. Key Applications: Cereals drying, pulses drying, and oil seeds drying represent the major application segments shaping overall market demand. Market Dynamics Drivers The grain dryer market is being propelled by the growing demand for preserved grains worldwide, supported by the rising emphasis on improving storage efficiency and reducing post-harvest losses. Additionally, increasing adoption in developing countries is expanding the addressable market size as farmers and food processors invest in modern drying technologies to enhance productivity. Restraints However, market growth faces challenges including economic uncertainties, regulatory hurdles, supply-chain disruptions, and competitive pressures. These factors may impede adoption rates across certain regions or market segments, necessitating industry players to adapt through innovation, cost-efficiencies, and regulatory compliance strategies. Opportunities Emerging technologies represent key growth avenues in the sector, particularly the integration of precision drying systems and smart-farming connectivity, which are expected to open new possibilities for yield optimization and process efficiency. Firms that address existing restraints strategically and leverage these innovations can unlock untapped growth potential and achieve a competitive edge across developing and mature markets alike. Top Market Players The report profiles major companies shaping the competitive landscape, including: Cimbria Cfcai Group Bühler GSI Brock Petkus Technologie Sukup Manufacturing Alvan Blanch Fratelli Pedrotti Mecmar Skiold Polnet Stela Shivvers Mathews Company Market Segmentation By Type Stationary Grain Dryer Mobile Grain Dryer By Application Cereals Drying Pulses Drying Oil Seeds Drying By Region North America Europe Asia-Pacific (APAC) Middle East & Africa Latin America (LATAM) About the Report The Global Grain Dryer Market Size, Share and Trends Analysis Report 2023-2031 delivers detailed insights across revenue forecasts, competitive landscape assessments, regional and segment analysis, industry drivers, restraints, opportunities, and emerging commercial developments. The report provides comprehensive coverage of market metrics, strategic insights, and forecast analysis to support business decisions and growth strategies in the global grain dryer sector.

Tissue Diagnostics Market: Unlocking Growth Potential and Addressing Challenges United States of America – October 16, 2025 – The Insight Partners is proud to announce its newest market report, “Tissue Diagnostics Market: An In-depth Analysis of the Tissue Diagnostics Market”. The report provides a holistic view of the tissue diagnostics market and describes the current scenario as well as growth estimates during the forecast period. Explore more - https://www.theinsightpartners.com/reports/tissue-diagnostics-market Overview of the Tissue Diagnostics Market The tissue diagnostics market has been growing steadily, propelled by increasing cancer incidence worldwide, rising demand for precision medicine, technological innovation (digital pathology, AI, automated imaging), and greater healthcare infrastructure investment. Pathology labs, hospitals, and diagnostic centers are increasingly adopting advanced techniques like immunohistochemistry (IHC), in situ hybridization (ISH), and digital tools to enable earlier, more accurate disease diagnosis and better treatment planning. ________________________________________ Key Findings and Insights Market Size and Growth • In 2024, the global tissue diagnostics market was estimated at around USD 8.72 billion. • By 2030, the market is projected to reach approximately USD 14.03 billion, growing at a CAGR of about 8.4% over 2025-2030. Key Factors Affecting the Tissue Diagnostics Market • Rising Prevalence of Chronic Diseases, Especially Cancer: Increasing global incidence of cancer is driving demand for reliable tissue diagnostics. • Growing Geriatric Population: Older populations are more susceptible to cancers and chronic conditions, increasing the need for diagnostic services. • Precision Medicine / Personalized Therapy: The shift toward tailored treatments based on biomarkers and tissue-based diagnostics inflates demand for higher-resolution, reliable diagnostics. • Technology Advancements: Digital pathology, AI/ML tools, automated imaging, better reagents, improved IHC/ISH methods are improving accuracy, speed, and scalability. • Healthcare Spending & Infrastructure Development: Especially in North America and Asia-Pacific, increasing investments in diagnostic capacity, lab infrastructure, and awareness are facilitating market growth. Market Segmentation • By Technology / Technique:  – Immunohistochemistry (IHC) – leading revenue share (~25-26% in 2024)  – In Situ Hybridization (ISH)  – Digital Pathology & Workflow technologies – fastest growing segment in many reports • By Application / Disease Type:  – Breast cancer diagnostics is a major application, holding a large share of tissue diagnostics usage.  – Other cancer types / disease applications following behind. • By End-User / Modality:  – Hospitals and diagnostic centers dominate use cases.  – Research / pharma / Contract Research Organizations (CROs) also significant, especially for novel diagnostics / biomarker discovery. • By Region:  – North America is the largest market by revenue as of 2024.  – Asia-Pacific is among the fastest growing regions, driven by rising healthcare investment and cancer burden. Spotting Emerging Trends Technological Advancements • Integration of AI / Machine Learning with digital pathology for slide scanning, image interpretation, and predictive diagnostics. • Increased automation in IHC/ISH workflows to improve throughput, reduce human error, and speed diagnostics. • Use of novel imaging and multiplexing techniques enabling more biomarkers per tissue sample. Changing Consumer / Institutional Preferences • Demand for faster turnaround times in diagnostic labs. • Preference for non-invasive or minimally invasive diagnostics where possible, though tissue biopsy remains standard. • Growing emphasis on diagnostic accuracy and reliability, particularly for guiding therapy. Regulatory Changes • Increased scrutiny of diagnostic device approval, validation, and compliance, especially for AI-based tools. • Policies promoting early cancer screening, reimbursement programs for diagnostics, which can encourage adoption. • Standards and guidelines evolving for digital pathology and diagnostic data management. Growth Opportunities 1. Digital Pathology and AI Platforms: Companies offering end-to-end digital slide scanning, cloud analytics, and AI-assisted diagnosis can capture growing demand. 2. Biomarker Discoveries and Companion Diagnostics: Tissue diagnostics tied to drug development / therapy matching—especially in oncology—is a promising high‐margin segment. 3. Emerging Markets Expansion: Asia-Pacific, Latin America, and parts of MEA where cancer incidence is rising and diagnostic infrastructure is being upgraded. 4. Improved Workflows and Lab Automation: Products & services that reduce time, cost, and labor for labs (automation, software workflow, remote reading). 5. Consumables & Reagents: Recurrent demand for high-quality reagents, antibodies, probes, slides – making consumables a stable revenue base. 6. Strategic Collaborations and Reimbursement Initiatives: Partnerships between diagnostics firms, hospitals, regulators to expand screening programs; better insurance/reimbursement coverage for advanced diagnostics. Conclusion The Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2030 report offers essential insights for companies looking to enter or scale in this field. With accelerating disease burden, especially cancer, coupled with technological innovations in digital pathology, AI, imaging, and biomarkers, the tissue diagnostics market is poised for significant growth. Success will depend on balancing regulatory compliance, diagnostic accuracy, speed, and cost-effectiveness. Players that can offer robust, validated technologies and expand into underserved regions while maintaining quality standards are best placed to seize market share in coming years.

General Purpose Test Equipment Market Braces for Disruption by 2031 New York, US – October 06, 2025 – A new report from The Insight Partners, titled “General Purpose Test Equipment Market Share, Size, Trends, and Forecast by 2031,” suggests that the road ahead for the General Purpose Test Equipment (GPTE) market may be more complex than previously anticipated. Although advancements in technologies like 5G, IoT, and automation once guaranteed consistent growth, the current landscape reveals signs of transformation, consolidation, and emerging pressures that are reshaping market trajectories. Rather than a straightforward growth surge, the GPTE market is entering a phase defined by strategic realignment, where companies are shifting focus from broad-based expansion to targeted innovation, risk management, and operational efficiency. While opportunities remain, especially in high-demand sectors like aerospace and telecommunications, the pace and nature of market evolution are changing. Emerging Market Realities Redefine Growth Path Although there is continued demand for test equipment in technologically advanced sectors, several factors are changing how—and where—that demand manifests. • Demand Deceleration in Mature Markets: As 5G infrastructure solidifies and IoT applications become commonplace in developed regions, test equipment sales are seeing slower growth. Many enterprises are maintaining existing systems rather than investing in entirely new hardware, causing a shift from hardware sales to software updates and modular upgrades. • Resource Allocation Challenges: Inflation, supply chain instability, and geopolitical tensions have tightened R&D and capital budgets across industries. This has led to a more conservative approach in test equipment procurement, particularly among small and medium enterprises (SMEs) that traditionally drive a significant portion of the market. • Evolving Product Development Cycles: The increasing complexity of devices and systems being developed today has extended testing timelines, but also narrowed the scope of required equipment. Customers now seek multi-functional, adaptive solutions rather than generic tools, pushing vendors to rethink their portfolios. Strategic Developments Reflect Market Adaptation Leading players are no longer competing on price or speed alone; they are investing in specialization and aligning closely with emerging technical standards. • Anritsu Corporation is adapting to regulatory shifts by enhancing its product line to meet public safety and emergency communication standards, such as the NG eCall test system certified in mid-2025. • The company’s continued focus on 5G device testing—with the release of new MT8000A software—also reflects a pivot toward higher-end applications that demand greater RF precision and flexibility, rather than catering to low- to mid-range test needs. • Lauterbach GmbH is expanding compatibility to cater to more specific platforms like PX5 RTOS and automotive-grade microcontrollers from NXP. These are not general-use upgrades—they’re designed for developers dealing with advanced embedded systems and power-sensitive automotive applications. • Rohde & Schwarz has introduced higher-frequency vector network analyzers aimed at advanced RF testing scenarios, which are only relevant to select industries like satellite communications, radar systems, and aerospace engineering. These strategic moves reveal a market transition, from general purpose to purpose-built. https://www.theinsightpartners.com/reports/general-purpose-test-equipment-market

Rare Disease Drugs Market  Revenue Forecast, Future Scope, Challenges, Growth Drivers The global Rare Disease Drugs Market is poised for significant expansion, projected to grow from USD 179.5 billion in 2025 to USD 364.1 billion by 2033, at a CAGR of 9.6%. This surge is fueled by increasing awareness, patient advocacy, and supportive regulatory frameworks like the U.S. Orphan Drug Act and similar initiatives in the EU and Japan. Biopharmaceutical companies are leveraging cutting-edge technologies—such as CRISPR gene editing, RNA-based therapeutics, and monoclonal antibodies—to develop targeted treatments for conditions with limited or no existing therapies. Oncology leads the therapy segment, accounting for over 31% of the market share, driven by rare cancers like sarcomas and pediatric malignancies. For a deeper dive into market segmentation and forecasts, check out the full report on https://m2squareconsultancy.com/reports/rare-disease-drugs-market Biologics dominate the drug type category due to their precision and efficacy in treating complex disorders, while hospital pharmacies remain the primary distribution channel, given the specialized nature of these treatments. North America holds the largest market share, but Asia-Pacific is expected to grow fastest, thanks to rising investments, improved diagnostics, and national rare disease registries in countries like China, Japan, and India Get More Reports Links https://m2squareconsultancy.com/reports/sickle-cell-anemia-testing-and-screening-market https://m2squareconsultancy.com/reports/urine-testing-cups-market https://m2squareconsultancy.com/reports/global-vaccines-market https://m2squareconsultancy.com/reports/surgical-instruments-market https://m2squareconsultancy.com/reports/predictive-analytics-market https://m2squareconsultancy.com/reports/smart-cities-market